Insulin biosimilar (Wockhardt)

胰岛素生物类似药 (Wockhardt)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin biosimilar (Wockhardt)
Drug Alias Name胰岛素生物仿制药 (Wockhardt)Recombinant (r-DNA) regular short acting human insulinInsulin follow-on biologicinsulin follow-on biologicWosulin®-R +[8] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus, Type 1
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2003/10/01
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWockhardt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A